149 related articles for article (PubMed ID: 36768349)
1. Actin-like Protein 6A Expression Correlates with Cancer Stem Cell-like Features and Poor Prognosis in Ovarian Cancer.
Chen PM; Wong CN; Wong CN; Chu PY
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768349
[TBL] [Abstract][Full Text] [Related]
2. ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.
Xiao Y; Lin FT; Lin WC
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33408251
[TBL] [Abstract][Full Text] [Related]
3. Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma.
Sun W; Wang W; Lei J; Li H; Wu Y
Oncol Rep; 2017 Apr; 37(4):2405-2417. PubMed ID: 28260090
[TBL] [Abstract][Full Text] [Related]
4. ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.
Zeng Z; Yang H; Xiao S
BMC Cancer; 2018 Oct; 18(1):1020. PubMed ID: 30348114
[TBL] [Abstract][Full Text] [Related]
5. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
[TBL] [Abstract][Full Text] [Related]
6. ACTL6A suppresses p21
Shrestha S; Adhikary G; Xu W; Kandasamy S; Eckert RL
Oncogene; 2020 Sep; 39(36):5855-5866. PubMed ID: 32616890
[TBL] [Abstract][Full Text] [Related]
7. ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1.
Zhang J; Zhang J; Wei Y; Li Q; Wang Q
Cell Death Dis; 2019 Oct; 10(11):811. PubMed ID: 31649264
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a proliferation essential gene signature and actin-like 6A as potential biomarkers for predicting prognosis and neoadjuvant chemotherapy response in triple-positive breast cancer.
Li X; Luo S; Fu W; Huang M; Huang X; Kang S; Zhang J; Wang Q; Song C
Cancer; 2024 Apr; 130(S8):1435-1448. PubMed ID: 38358781
[TBL] [Abstract][Full Text] [Related]
9. Actin-like 6A enhances the proliferative and invasive capacities of laryngeal squamous cell carcinoma by potentiating the activation of YAP signaling.
Dang Y; Zhang L; Wang X
J Bioenerg Biomembr; 2020 Dec; 52(6):453-463. PubMed ID: 33067739
[TBL] [Abstract][Full Text] [Related]
10. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
11. Gene amplification of chromatin remodeling factor
Magarifuchi N; Iwasaki T; Katayama Y; Tomonaga T; Nakashima M; Narutomi F; Kato K; Oda Y
Oncol Lett; 2024 May; 27(5):196. PubMed ID: 38516682
[TBL] [Abstract][Full Text] [Related]
12. ACTL6A interacts with p53 in acute promyelocytic leukemia cell lines to affect differentiation via the Sox2/Notch1 signaling pathway.
Zhong PQ; Zhong L; Yao JJ; Liu DD; Yuan Z; Liu JM; Chen M; Yao SF; Zhao Y; Liu L; Li LW; Liu BZ
Cell Signal; 2019 Jan; 53():390-399. PubMed ID: 30448346
[TBL] [Abstract][Full Text] [Related]
13. ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis.
Yang Z; Zou S; Zhang Y; Zhang J; Zhang P; Xiao L; Xie Y; Meng M; Feng J; Kang L; Lee MH; Fang L
Nat Commun; 2023 Jul; 14(1):4193. PubMed ID: 37443154
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene.
Wang YL; Liang RH; Wang CY; Zhang RP; Wu SY; Han X; Zhang GL
Clin Transl Oncol; 2022 Jan; 24(1):84-92. PubMed ID: 34181232
[TBL] [Abstract][Full Text] [Related]
15. ACTL6A deficiency induces apoptosis through impairing DNA replication and inhibiting the ATR-Chk1 signaling in glioblastoma cells.
Hu X; Pei D; Ci M; Zhang G; Li B; Wang J; Shen Y; Zhai X; Liang P; Cui H
Biochem Biophys Res Commun; 2022 Apr; 599():148-155. PubMed ID: 35182941
[TBL] [Abstract][Full Text] [Related]
16. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
17. Actl6a protects embryonic stem cells from differentiating into primitive endoderm.
Lu W; Fang L; Ouyang B; Zhang X; Zhan S; Feng X; Bai Y; Han X; Kim H; He Q; Wan M; Shi FT; Feng XH; Liu D; Huang J; Songyang Z
Stem Cells; 2015 Jun; 33(6):1782-93. PubMed ID: 25802002
[TBL] [Abstract][Full Text] [Related]
18. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
19. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
20. Combining data from TCGA and GEO databases and reverse transcription quantitative PCR validation to identify gene prognostic markers in lung cancer.
Liu X; Wang J; Chen M; Liu S; Yu X; Wen F
Onco Targets Ther; 2019; 12():709-720. PubMed ID: 30718962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
